Feed Top Reports Pricing

⌘K

16:49:05·52d

SECFiling

SEC Form 10-K filed by Nuvation Bio Inc.

NUVB· Nuvation Bio Inc.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

NUVB
Nuvation Bio Inc.
Health Care

Recent analyst ratings

Nov 24UpdateTruist-
Nov 19UpdateB. Riley Securities$12.00
Sep 30UpdateJefferies$10.00
Apr 23UpdateCitizens JMP$6.00
Mar 27UpdateJefferies$10.00
Mar 26UpdateBTIG Research$5.00

Related

PR2d
/U P D A T E -- Nuvation Bio Inc./
PR2d
Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
INSIDER2d
SEC Form 4 filed by Wentworth Kerry
INSIDER2d
SEC Form 4 filed by Liu Dongfang
SEC2d
SEC Form DEFA14A filed by Nuvation Bio Inc.
PR3d
Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026
SEC6d
SEC Form 144 filed by Nuvation Bio Inc.
SEC13d
SEC Form DEF 14A filed by Nuvation Bio Inc.

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022